AbilityPharma announces a €7M investment from a European-Canadian syndicate of life sciences investors, including CTI Life Sciences Fund, Inveready, the EIC Fund, Fitalent and CDTI Innvierte

by Inveready Asset Management

The Catalan biopharmaceutical company Ability Pharmaceuticals, SA (AbilityPharma), focused on the development of innovative oral autophagy-inducing anticancer compounds, announces a €7M investment f...

Read more

AbilityPharma will secure 7 million euros with a collective investment campaign in Capital Cell of up to 2 million to finance itself until the results of its international phase 2b study in pancreatic cancer

by Capital Cell

The Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes a collective investment campaign of up to 2 million on the Capital C...

Read more

AbilityPharma receives a 1.6 million euro grant from the FDA and opens a crowdfunding campaign in Capital Cell

by Inveready Asset Management

The Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes the last stage of the investment round with which this year it will ...

Read more

AbilityPharma supera los 500.000€ en la primera fase de su ronda de financiación

by Capital Cell

Esta primera campaña ha conseguido una gran acogida por parte de los 187 inversores que ya han apostado por el proyecto de AbilityPharma, que tiene como objetivo convertir el cáncer, la segunda caus...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

BerriUp lanza una nueva convocatoria de ...

by BerriUp

BerriUp y Rural Kutxa han vuelto a unir fuerzas para lanzar su cuarta ...

Photos Stream